Background: Fibrosis-related diseases (FRD) include cerebral fibrosis, pulmonary fibrosis,
cardiac fibrosis, liver fibrosis, renal fibrosis, peritoneal fibrosis, etc. The effects of fibrosis can …

The prevalence of neurological/neurodegenerative diseases, such as Alzheimer's disease is
known to be increasing due to an aging population and is anticipated to further grow in the …

Fine particulate air pollution (PM 2.5) exposures are linked with Alzheimer's and Parkinson's
diseases (AD, PD). AD and PD neuropathological hallmarks are documented in children …

Abstract α-Synuclein (α-Syn) aggregates are key components of intracellular inclusion
bodies characteristic of Parkinson's disease (PD) and other synucleinopathies. Metal ions …

Quadruple aberrant hyperphosphorylated tau, beta-amyloid, α-synuclein and TDP-43
neuropathology and metal solid nanoparticles (NPs) are documented in the brains of …

Analyzing the therapeutic potential of a therapeutic biomolecule requires an understanding
of how it may interact with proteins and modify their corresponding functions. α-Synuclein is …

Protein misfolding diseases, such as prion diseases, Alzheimer's, and Parkinson's, share a
common molecular mechanism involving the misfolding and aggregation of specific …

Misfolded proteins associated with various neurodegenerative diseases often accumulate in
tissues or circulate in biological fluids years before the clinical onset, thus representing ideal …

There are several studies reporting that different plant-based metabolites are potential
inhibitors of protein amyloid fibrillation. As chemical features of metabolites can regulate …

Parkinson's disease (PD) is one of the most common neurodegenerative disorders that is
implicated in aging populations. As numerous developed nations are experiencing …